Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:September 2010
End Date:January 2013

Use our guide to learn which trials are right for you!

(OSKIRA-1): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate


The purpose of the study is to evaluate the effectiveness of two dosing regimens of
fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking
methotrexate but not responding. The study will last for 1 year.



We found this trial at
3
sites
?
mi
from
New Haven, CT
Click here to add this to my saved trials
?
mi
from
Asheville, NC
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials